FCHS News 2.6400 First Choice Healthcare Solutions (FCHS)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 17, 2014 at 7:03 AM

First Choice Healthcare Solutions (FCHS) 2.6400 $FCHS

First Choice Healthcare Solutions Announces Record 2013 Year-End Results
Marketwire - Tue Apr 01, 7:32AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice"

, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced its financial results for the fiscal year ended December 31, 2013.

First Choice Healthcare Solutions Announces Preliminary Fourth Quarter and Full Year 2013 Unaudited Revenue Results
Marketwire - Thu Jan 16, 2:15PM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS"

, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced preliminary unaudited revenues for the three months and full year ended December 31, 2013.

First Choice Healthcare to Present at "TEN," Noble Financial Capital Markets' Tenth Annual Equity Conference
Marketwire - Wed Jan 15, 12:57PM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS"

, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced that the Company is scheduled to present at "TEN," Noble Financial Capital Markets' Tenth Annual Equity Conference to be held January 19-22, 2014 at Club Med's Sandpiper Bay Resort & Spa in Port Saint Lucie, Florida. The Company's management team will also be available for one-on-one meetings with Conference attendees.

First Choice Healthcare to Present at National Investment Banking Association's 129th Investment Conference
Marketwire - Mon Dec 09, 7:30AM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS"

, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced that it has been invited to present at the National Investment Banking Association's (NIBA) 129th Investment Conference to be held in Las Vegas on December 11-13, 2013.

First Choice Healthcare Solutions Announces Key New Additions to First Choice Medical Group's Clinical Team
Marketwire - Thu Dec 05, 7:30AM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS"

in Melbourne, Florida.

First Choice Healthcare Reports Third Quarter 2013 Results
Marketwire - Fri Nov 15, 12:38PM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice"

, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced its third quarter results for the three and nine months ended September 30, 2013.

First Choice Healthcare Completes $2 Million Strategic Financing With Hillair Capital Investments
Marketwire - Wed Nov 13, 7:30AM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS"

, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced that it has raised $2 million in gross proceeds through the sale of a Convertible Debenture to micro-cap institutional investment firm Hillair Capital Investments L.P.

First Choice Healthcare Solutions Issues Formal Corporate Update
Marketwire - Mon Nov 11, 7:30AM CST
Chris Romandetti, Chairman, President and CEO of First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS"

, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today commented on recent developments, key growth strategies and anticipated milestones expected to be achieved by the Company in the very near term. Romandetti stated:

First Choice Healthcare Solutions, Inc. Subsidiary Secures $1.5 Million A/R Line of Credit
Marketwire - Fri Jun 28, 6:30AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) (OTCBB: FCHS) announced today that its subsidiary, First Choice Medical Group, ("FCMG"

has secured a $1.5 million A/R line of credit from CT Capital, Ltd. d/b/a CT Capital, LP.

First Choice Healthcare Solutions, Inc. Reports 2013 First Quarter Earnings
Marketwire - Fri May 17, 6:30AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) (OTCBB: FCHS) announced today the 2013 first quarter financial and operational results.

/ CORRECTION - First Choice Healthcare Solutions, Inc. Reports Positive EBIDTA in Opening Year of Operations
Marketwire - Thu Apr 04, 1:30PM CDT
In the news release, "First Choice Healthcare Solutions, Inc. Reports Positive EBIDTA in Opening Year of Operations," issued earlier today by First Choice Healthcare Solutions (OTCQB: FCHS) (OTCBB: FCHS), we are advised by the company that the quoted text in the fifth paragraph should begin "With the first quarter of 2013 already completed, we are confident the Company will report an outstanding $1.4MM in gross revenues for Q1 2013, well outperforming Q1 2012 gross revenues of $330,000, with a confident $275,000 of positive EBIDTA for Q1 2013. The Center of Excellence was operating only at 6% of its attainable capacity at year-end 2012 since it was just launched last year." rather than "With the first quarter of 2013 already completed, we are confident the Company will report an outstanding $275,000 or more in first quarter revenue plus positive EBIDTA. The Center of Excellence was operating only at 6% of its capacity by the end of 2012 since it was just launched last year." as originally issued. Complete c

First Choice Healthcare Solutions, Inc. Reports Positive EBIDTA in Opening Year of Operations
Marketwire - Thu Apr 04, 6:30AM CDT
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) (OTCBB: FCHS) today reported solid progress in its 2012 year-end results.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...